<DOC>
	<DOCNO>NCT00853528</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiosurgery send x-ray directly tumor cause less damage normal tissue . It may also help patient spinal metastasis live comfortably . PURPOSE : This phase I trial study side effect best dose stereotactic radiosurgery treat patient spinal metastasis .</brief_summary>
	<brief_title>Stereotactic Radiosurgery Treating Patients With Spinal Metastases</brief_title>
	<detailed_description>OBJECTIVES : - To implement CyberKnife® technology improve palliation patient spinal metastasis . - To determine maximum tolerate dose CyberKnife® hypofractionated stereotactic radiosurgery patient . - To evaluate functional diffusion MRI parameter spinal cord tumor treatment Cyberknife® radiosurgery . OUTLINE : Patients undergo placement gold fiducial marker time open surgical resection percutaneous needle biopsy . Patients undergo CyberKnife® hypofractionated stereotactic radiosurgery 30-90 minute daily 2-3 day . Patients undergo functional MRI diffusion tensor image baseline 6 week 6 month completion treatment . Patients also complete pain questionnaire baseline 3 , 6 , 9 , 12 , 18 , 24 month completion treatment . After completion study treatment , patient follow periodically 2 year .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm metastatic spinal tumor Localized spinal metastasis , define one following : Solitary spinal metastasis Two contiguous spinal level No 2 adjacent spinal level involve single tumor Involvement ≤ 3 separate site ( e.g. , C5 , T5 , T12 ) Tumor size ≤ 5 cm PATIENT CHARACTERISTICS : Karnofsky performance status 60100 % Life expectancy ≥ 6 month Negative pregnancy test Fertile patient must use effective contraception Must ambulatory Not pregnant nursing No spinal instability No rapid neurological decline No bony retropulsions cause neurological abnormality No total paraplegia &gt; 48 hour No psychological issue would preclude completion study treatment PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior treatment spinal tumor would result potential overlap radiotherapy field No treatment expect exceed spinal cord tolerance regional normal tissue tolerance No tumor exquisitely radiosensitive control conventional radiotherapy ( e.g. , lymphoma , leukemia , multiple myeloma , germ cell tumor )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>spinal cord metastasis</keyword>
</DOC>